The truth about rosiglitazone (avandia).
Ledbetter
Carol
C
Oregon Health and Science University, School of Nursing, La Grande, OR, USA.
Laustsen
Gary
G
D004348:Drug Labeling; D016903:Drug Monitoring; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009722:Nurse Practitioners; D000077154:Rosiglitazone; D017751:Safety Management; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone